SPDR S&P Biotech ETF (XBI) option implied volatility flat
SPDR S&P Biotech ETF (NYSE: XBI) 30-day option implied volatility is at 36; compared to its 52-week range of 25 to 44 after speculation in Korean press that Samsung Group is in talks to acquire Biogen (BIIB). Call put ratio 1.3 calls to 1 put.
Create E-mail Alert Related Categories
OptionsRelated Entities
Standard & Poor's, Options, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share